All 1 tracked stories fall under one category: fda-approval. flu vaccine is most often covered alongside American Medical Association, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention flu vaccine, all published on September 13, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about flu vaccine
All 1 tracked stories fall under one category: fda-approval. flu vaccine is most often covered alongside American Medical Association, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention flu vaccine, all published on September 13, 2026. Each carries 2 original sources on average.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering flu vaccine. Shared-story counts are live from our verified record — not editorial picks.
The FDA has cleared updated COVID-19 vaccines from Pfizer, Moderna, and Novavax for 2026-27, targeting the XFG/Stratus strain. The decision resets the competitive landscape for seasonal vaccine makers.